Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Directorate Change

9 Feb 2011 11:15

RNS Number : 9398A
Consort Medical PLC
09 February 2011
 



 

 

 

News Release

 

9 February 2011

 

 

Consort Medical plc

 

Consort Medical announces the appointment of Dr. Lynn Drummond to the Board

 

Consort Medical plc ("Consort") is pleased to announce the appointment of Dr. Lynn Drummond as a Board member, effective today.

 

Dr. Drummond has a strong track record within the life sciences sector, bringing over twenty years of management and advisory experience. Lynn spent 16 years at Rothschild in London most recently as a Managing Director within the investment banking division, with a particular focus on transactions within the healthcare sector. Prior to this she worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. Lynn is also a non executive director of Alimentary Health in Ireland.

 

Dr. Drummond holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is also a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

 

Commenting on Dr. Drummond's appointment, Peter Fellner, Chairman said:

"We are delighted that Lynn is joining Consort as a Board member. Lynn brings a tremendous set of skills and experience to the Board and we look forward to working with her."

 

Dr. Lynn Drummond commented:

"Consort has an established reputation as a leader in pharmaceutical drug delivery systems and I look forward to being a part of this growing business and working with the Board to deliver value for shareholders."

 

 

END

 

Enquiries

Consort Medical plc

Tel: +44 (0) 1442 867920

Jonathan Glenn, Chief Executive Officer

Toby Woolrych, Group Finance Director

Brunswick

Tel: +44 (0) 20 7404 5959

Jon Coles/Justine McIlroy

 

Consort Medical plc is a leader in medical devices for drug delivery and device technologies. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.

 

Consort Medical develops and manufactures metered dose inhaler valves, autoinjectors, needle free injectors, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits, video laryngoscopes and laryngeal tubes. The Group has a Head Office in Hemel Hempstead, UK and manufacturing facilities in King's Lynn, Norfolk, and Nelson, Lancashire in the UK, Indianapolis, Indiana and Kent, Ohio in the US. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGGZMLDGMZM
Date   Source Headline
8th Apr 20159:57 amRNSDirector Declaration
1st Apr 20159:07 amRNSTotal Voting Rights
23rd Mar 20152:44 pmRNSHolding(s) in Company
12th Mar 20152:53 pmRNSHolding(s) in Company - Replacement
11th Mar 20159:10 amRNSHolding(s) in Company
23rd Feb 20157:00 amRNSVoke® licence - variation granted by MHRA
11th Feb 201511:12 amRNSDirectorate Change
4th Feb 20157:00 amRNSIntegrated Dose Counter Supply Agreement
3rd Feb 201511:37 amRNSHolding(s) in Company
2nd Feb 20159:43 amRNSTotal Voting Rights
29th Jan 20157:00 amRNS£2.2m investment in Atlas Genetics Series C
26th Jan 201512:47 pmRNSDirector/PDMR Shareholding
6th Jan 20153:48 pmRNSDirector/PDMR Shareholding
5th Jan 20152:46 pmRNSTotal Voting Rights
9th Dec 201410:37 amRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSHalf Yearly Report
2nd Dec 20141:43 pmRNSBlocklisting Interim Review
28th Nov 201411:31 amBUSForm 8.3 - CSR PLC - Replacement
27th Nov 20142:53 pmBUSForm 8.3 - CSR PLC
27th Nov 20149:00 amRNSHolding(s) in Company
14th Nov 20142:23 pmRNSHolding(s) in Company
12th Nov 201411:09 amRNSAcquisition of Aesica Holdco Limited
12th Nov 201410:06 amRNSTotal Voting Rights
7th Nov 201410:23 amRNSHolding(s) in Company
6th Nov 201412:58 pmRNSHolding(s) in Company
5th Nov 201412:26 pmRNSAdditional Listing
5th Nov 201410:04 amRNSHolding(s) in Company
4th Nov 201412:45 pmRNSTotal Voting Rights
4th Nov 201412:36 pmRNSDirector/PDMR Shareholding
3rd Nov 20149:35 amRNSResults of Rump Placing
3rd Nov 20147:00 amRNSResults of Rights Issue
29th Oct 20144:51 pmRNSDirector/PDMR Shareholding
28th Oct 20145:02 pmRNSHolding(s) in Company
22nd Oct 20147:00 amRNSDevelopment Contract Award
21st Oct 20142:28 pmRNSGerman anti-trust clearance
17th Oct 20148:02 amRNSADMISSION OF NEW ORDINARY SHARES
16th Oct 201412:00 pmRNSResult of EGM
15th Oct 20141:30 pmRNSBlocklisting Interim Review
6th Oct 201410:19 amRNSDirector/PDMR Shareholding
2nd Oct 20141:55 pmRNSHolding(s) in Company
1st Oct 201411:47 amRNSTotal Voting Rights
30th Sep 20143:44 pmRNSPublication of Prospectus
30th Sep 20147:00 amRNSProposed acquisition of Aesica Holdco Limited
12th Sep 20147:00 amRNSMHRA Authorisation of the Voke Inhaler
5th Sep 20143:06 pmRNSHolding(s) in Company
4th Sep 20143:28 pmRNSResult of AGM
4th Sep 20147:00 amRNSInterim Management Statement
29th Jul 20144:28 pmRNSDirector/PDMR Shareholding
29th Jul 201412:10 pmRNSAnnual Financial Report
25th Jul 201410:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.